Literature DB >> 4071952

Streptococcus suis infections in pigs in the Netherlands (Part I).

U Vecht, L A van Leengoed, E R Verheijen.   

Abstract

Data are presented on the incidence of various streptococcal infections in pigs in the Netherlands. 314 Strains isolated in the course of routine post-mortem diagnosis were examined. The most frequently occurring streptococcus was S. subacidus (bio) type II which was isolated in 31.2% of the cases. S. suis type 2 (Serogroup R) and S. equisimilis (Serogroup C) constituted 16.2% and 13.7% of the isolates respectively. Besides meningitis, endocarditis and polyserositis S. suis type 2 infections may frequently be associated with pneumonia (42%). The biochemical profiles of the various S. suis and S. subacidus (bio) types are presented. The profile of both species is almost identical. It seems justified to use the name S. suis for strains with this characteristic profile and to abandon the name S. subacidus. Haemolysis does not appear to be a suitable characteristic to screen for S. subacidus/S. suis types. In comparing three serological methods for typing S. suis type 2, gel precipitation using Fuller's extract and slide agglutination give an almost 100% correlation. These two methods are recommended for serotyping.

Entities:  

Mesh:

Year:  1985        PMID: 4071952     DOI: 10.1080/01652176.1985.9694005

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  21 in total

1.  Selection of virulence-associated determinants of Streptococcus suis serotype 2 by in vivo complementation.

Authors:  H E Smith; H Buijs; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2.

Authors:  H E Smith; U Vecht; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  A hypothetical model of host-pathogen interaction of Streptococcus suis in the gastro-intestinal tract.

Authors:  Maria Laura Ferrando; Constance Schultsz
Journal:  Gut Microbes       Date:  2016

4.  Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs.

Authors:  H E Smith; U Vecht; H J Wisselink; N Stockhofe-Zurwieden; Y Biermann; M A Smits
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Streptococcus suis isolated from pigs in Finland.

Authors:  L Sihvonen; D N Kurl; J Henrichsen
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

6.  Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.

Authors:  H E Smith; M Damman; J van der Velde; F Wagenaar; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Distribution of environmentally regulated genes of Streptococcus suis serotype 2 among S. suis serotypes and other organisms.

Authors:  Astrid De Greeff; Herma Buys; Robin Verhaar; Loek Van Alphen; Hilde E Smith
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Multiplex PCR assays for simultaneous detection of six major serotypes and two virulence-associated phenotypes of Streptococcus suis in tonsillar specimens from pigs.

Authors:  Henk J Wisselink; Jeroen J Joosten; Hilde E Smith
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.

Authors:  A A Jacobs; P L Loeffen; A J van den Berg; P K Storm
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains.

Authors:  H E Smith; F H Reek; U Vecht; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.